Brief: Aadi Bioscience Announces Improved Anti-Tumor Activity Of Kras Inhibitors With NAB-Sirolimus

Whitehawk Therapeutics

27/10/2022 14:14

Oct 27 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES IMPROVED ANTI-TUMOR ACTIVITY OF
KRAS
INHIBITORS IN COMBINATION WITH NAB-SIROLIMUS AT THE 34TH
EORTC-NCI-AACR SYMPOSIUM

Source text for Eikon:  ID:nPn5zl0c5a 
Further company coverage:  AADI.O 
 ((Reuters.Briefs@thomsonreuters.com;))